Kathmere Capital Management LLC Purchases 2,011 Shares of Aflac Incorporated (NYSE:AFL)

Kathmere Capital Management LLC raised its position in shares of Aflac Incorporated (NYSE:AFL) by 17.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,450 shares of the financial services provider’s stock after purchasing an additional 2,011 shares during the period. Kathmere Capital Management LLC’s holdings in Aflac were worth $1,201,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AFL. Y.D. More Investments Ltd acquired a new position in shares of Aflac during the 2nd quarter worth $25,000. Atwood & Palmer Inc. boosted its holdings in shares of Aflac by 80.0% during the 1st quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 140 shares in the last quarter. OFI Invest Asset Management acquired a new stake in shares of Aflac during the 1st quarter valued at $29,000. Dixon Mitchell Investment Counsel Inc. bought a new stake in Aflac during the 1st quarter worth $34,000. Finally, Cedar Wealth Management LLC acquired a new position in Aflac in the 1st quarter worth about $50,000. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Performance

Shares of Aflac stock opened at $110.59 on Friday. The company has a market cap of $62.84 billion, a P/E ratio of 12.21, a PEG ratio of 2.60 and a beta of 0.95. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29. The business has a 50-day moving average price of $104.15 and a two-hundred day moving average price of $92.65. Aflac Incorporated has a 1-year low of $74.89 and a 1-year high of $111.14.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.23. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company’s revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.58 earnings per share. As a group, analysts anticipate that Aflac Incorporated will post 6.75 EPS for the current year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.81%. Aflac’s dividend payout ratio is currently 22.08%.

Insider Activity

In related news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now directly owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.90% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Truist Financial lifted their price target on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Barclays began coverage on shares of Aflac in a research report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price on the stock. Evercore ISI boosted their target price on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a report on Thursday. UBS Group raised their price target on shares of Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research note on Wednesday, August 14th. Finally, Piper Sandler lifted their price target on shares of Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Friday, June 28th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Aflac has an average rating of “Hold” and a consensus target price of $93.36.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.